Medistim ASA (OSL:MEDI)
Norway flag Norway · Delayed Price · Currency is NOK
206.00
+3.00 (1.48%)
At close: Mar 13, 2026

Medistim ASA Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,7664,7352,7383,9124,2166,693
Market Cap Growth
33.97%72.95%-30.01%-7.22%-37.01%47.10%
Enterprise Value
3,5924,5992,6183,7904,1116,629
Last Close Price
206.00259.00144.18201.40214.03335.63
PE Ratio
23.6529.7426.3737.6836.9973.64
Forward PE
24.3129.1025.3433.8039.9461.56
PS Ratio
5.386.774.927.518.6716.02
PB Ratio
8.0410.116.279.8311.4721.87
P/TBV Ratio
10.0912.697.2611.1012.7124.26
P/FCF Ratio
-24.7219.9838.0540.4555.79
P/OCF Ratio
19.6624.7219.1332.8237.1552.55
EV/Sales Ratio
5.136.574.717.278.4515.87
EV/EBITDA Ratio
17.1021.8917.8425.8326.1152.09
EV/EBIT Ratio
18.3123.4419.9728.8329.1059.73
EV/FCF Ratio
-24.0119.1136.8639.4355.26
Debt / Equity Ratio
0.080.080.080.040.050.08
Debt / EBITDA Ratio
0.180.180.220.110.100.18
Debt / FCF Ratio
0.200.200.250.170.160.20
Net Debt / Equity Ratio
-0.37-0.37-0.33-0.34-0.37-0.34
Net Debt / EBITDA Ratio
-0.83-0.83-0.99-0.93-0.86-0.83
Net Debt / FCF Ratio
-0.91-0.91-1.06-1.32-1.30-0.88
Asset Turnover
1.131.131.031.051.101.12
Inventory Turnover
0.800.800.740.871.010.93
Quick Ratio
2.212.212.412.532.642.62
Current Ratio
3.343.344.004.153.873.95
Return on Equity (ROE)
35.18%35.18%24.88%27.12%33.83%32.30%
Return on Assets (ROA)
19.85%19.85%15.16%16.62%19.93%18.52%
Return on Invested Capital (ROIC)
52.43%51.58%36.63%40.87%50.92%41.64%
Return on Capital Employed (ROCE)
37.90%37.90%28.00%31.90%36.90%34.10%
Earnings Yield
4.23%3.36%3.79%2.65%2.70%1.36%
FCF Yield
-4.05%5.00%2.63%2.47%1.79%
Dividend Yield
3.88%3.09%4.16%2.23%2.10%1.12%
Payout Ratio
68.76%68.75%79.37%79.15%60.01%60.11%
Buyback Yield / Dilution
0.21%0.21%-0.10%-0.10%-0.15%-0.07%
Total Shareholder Return
4.09%3.30%4.06%2.13%1.95%1.05%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.